|
Real-time Estimate
Cboe BZX
10:05:04 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 6.155 USD | +0.74% |
|
-2.08% | +7.17% |
| 09-20 | Ultralife Corporation(NasdaqGM:ULBI) dropped from S&P Global BMI Index | CI |
| 08-07 | Ultralife Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Company Valuation: Ultralife Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 103.1 | 97.13 | 62.28 | 111.4 | 123.9 | 95.23 |
| Change | - | -5.75% | -35.88% | 78.95% | 11.15% | -23.12% |
| Enterprise Value (EV) 1 | 95.97 | 112.2 | 80.07 | 130.3 | 175.4 | 138.9 |
| Change | - | 16.9% | -28.62% | 62.75% | 34.59% | -20.83% |
| P/E | 19.7x | -414x | -386x | 15.5x | 19.6x | -16.1x |
| PBR | 0.88x | 0.83x | 0.54x | 0.89x | 0.92x | 0.73x |
| PEG | - | 4x | 12.3x | -0x | -1.4x | 0x |
| Capitalization / Revenue | 0.96x | 0.99x | 0.47x | 0.7x | 0.75x | 0.5x |
| EV / Revenue | 0.89x | 1.14x | 0.61x | 0.82x | 1.07x | 0.73x |
| EV / EBITDA | 11.1x | 27.7x | 14.8x | 9.74x | 12.4x | 9.86x |
| EV / EBIT | 16.8x | 220x | 83.2x | 13.8x | 17.6x | 16.2x |
| EV / FCF | 6.52x | -35x | -49.9x | -25x | 79.2x | 21.7x |
| FCF Yield | 15.3% | -2.86% | -2% | -4% | 1.26% | 4.61% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | 0.329 | -0.0146 | -0.009999 | 0.44 | 0.38 | -0.3544 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 107.7 | 98.27 | 131.8 | 158.6 | 164.5 | 191.2 |
| EBITDA 1 | 8.636 | 4.049 | 5.422 | 13.39 | 14.12 | 14.08 |
| EBIT 1 | 5.701 | 0.51 | 0.963 | 9.475 | 9.965 | 8.579 |
| Net income 1 | 5.232 | -0.234 | -0.119 | 7.197 | 6.312 | -5.898 |
| Net Debt 1 | -7.088 | 15.05 | 17.8 | 18.88 | 51.53 | 43.64 |
| Reference price 2 | 6.470 | 6.040 | 3.860 | 6.820 | 7.450 | 5.720 |
| Nbr of stocks (in thousands) | 15,928 | 16,081 | 16,134 | 16,340 | 16,627 | 16,649 |
| Announcement Date | 2/4/21 | 3/8/22 | 3/31/23 | 3/21/24 | 4/1/25 | 3/23/26 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 102M | ||
| 24.98x | 2.96x | 16.12x | 2.06% | 233B | ||
| 13.53x | 1.65x | 7.43x | 3.78% | 195B | ||
| 26.94x | 3.52x | 16.1x | 1.8% | 163B | ||
| 35.76x | 5.3x | 22.28x | 1.1% | 156B | ||
| 39.9x | 5.32x | 23.83x | 1.24% | 131B | ||
| 30.18x | 4.35x | 21.31x | 0.89% | 101B | ||
| 90.17x | 11.16x | 63.8x | 0.35% | 93.37B | ||
| 30.85x | 3.84x | 20.65x | 1.1% | 89.43B | ||
| 33.22x | 5.34x | 18.59x | 1.36% | 90.45B | ||
| Average | 36.17x | 4.83x | 23.35x | 1.52% | 125.15B | |
| Weighted average by Cap. | 32.65x | 4.32x | 20.82x | 1.75% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ULBI Stock
- Valuation Ultralife Corporation
Select your edition
All financial news and data tailored to specific country editions
















